Early Access — free while we kick the tires
EdgarHawk

Gottschalk Patrick E

Director

Director

Latest: Director buying · May 2026

2 filings analyzed · 1 company · Latest 2026-05-19

Never miss a filing from Gottschalk Patrick E

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
AMERICAN VANGUARD CORP AVD 2 0 Net buying

Activity

May 2026
medium
Buy
25,000 shares
$67,500
Significance 3/10

Director Patrick E Gottschalk bought 25,000 shares of AVD at $2.70; stock -54.9% from 52-week high, company unprofitable.

Director Patrick E Gottschalk purchased 25,000 shares at $2.70, bringing his holdings to 191,705 shares (+15.0% vs pre-transaction holdings), while AVD trades at $2.67 after declining -54.9% from its 52-week high of $5.92. The company reported negative net income of $-4,145,000.00 in the latest quarter and declining annual revenue growth of -5.9%, with full-year profitability also negative. The timing of this purchase amid substantial stock decline and operational underperformance warrants investor attention to underlying business trends.

medium
Buy
40,000 shares
$117,400
Significance 5/10

Director Gottschalk purchases 40,000 shares in 2 transactions at $2.92–$2.95 as AVD trades -54.9% from 52-week high amid unprofitability.

Gottschalk Patrick E executed 2 separate purchases totaling 40,000 shares for $117,400.00 on 2026-05-12 and 2026-05-13 at a blended average price of $2.94, increasing his holdings by 31.6% from 126.7K to 166.7K shares. The purchases occur while American Vanguard trades at $2.67, down 54.9% from its 52-week high of $5.92, and the company reported a negative net income of $-4.1M on quarterly revenue of $123.6M with annual revenue declining 5.9% year-over-year. His prior trading at this ticker (August 2023 buy) is not yet measurably timed at 90 days, and cross-ticker history shows only 1 prior buy with no pattern of well-timed acquisitions. The magnitude of this accumulation and the depressed price context relative to 52-week range merit attention, but the company's unprofitability and negative growth trajectory must factor into any investor assessment of the underlying risk.

Related insiders